Novartis adds nine new treatments under Pharmac deal

Novartis adds nine new treatments under Pharmac deal
By Paul McBeth Oct. 10 (BusinessDesk) - Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. The Pharmaceutical Management Agency will fund new treatments for multiple sclerosis, chronic obstructive pulmonary disease, chronic myeloid leukaemia, asthma, cystic fibrosis, Parkinson's and Alzheimer's in the drug buying agency's widest ranging single agreement, Pharmac and Novartis said in a joint statement. The terms of th...